ADVERSE EFFECTS FOLLOWING COVID-19 IMMUNIZATION IN KHYBER PAKHTUNKHWA: PAKISTAN

Authors

  • Ayesha Zafar Department of Neurology, Lady Reading Hospital Peshawar
  • Saima Abid Department of Community Medicine, Pak International Medical College Peshawar
  • Naveeda Sarwar Department of Community Medicine, Pak International Medical College Peshawar
  • Nauman Khan Department of Community Medicine, Pak International Medical College Peshawar
  • Nauman Khan Department of Community Medicine, Pak International Medical College Peshawar
  • Abdul Basit Department of Community Medicine, Pak International Medical College Peshawar
  • Rida Ubaid Department of Community Medicine, Pak International Medical College Peshawar
  • Zarafshan Johar Department of Community Medicine, Pak International Medical College Peshawar
  • Ulfat Kamal Department of Community Medicine, Pak International Medical College Peshawar
  • Hira Afridi Department of Community Medicine, Pak International Medical College Peshawar
  • Shehryar Khan Department of Community Medicine, Pak International Medical College Peshawar
  • Lutfullah Department of Community Medicine, Pak International Medical College Peshawar
  • Abdul Majid Department of Community Medicine, Pak International Medical College Peshawar
  • Mian Haider Khan Department of Community Medicine, Pak International Medical College Peshawar
  • M. Talha Khan Department of Community Medicine, Pak International Medical College Peshawar
  • Adil Zareef North West School of Medicine

DOI:

https://doi.org/10.33279/jkcd.v12i2.53

Keywords:

Pandemic, Covid 19 immunization, vaccine, pregnant, lactating mothers, AEFI, Pakistan

Abstract

Background:Adverse event following immunization (AEFI) is defi ned as any untoward medical occurrence following immunization and does not necessarily have a causal relationship with the use of the vaccine.
Objective: To determine the adverse eff ects following (AEFI) of COVID 19 vaccines in the population of Khyber Pakhtunkhwa (KP).
Methods and materials:Descriptive Cross-sectional study was conducted from June to September 2021on four hundred and three sample size of KP, selected using Cochran’s formula. AEFI’s were investigated among vaccinated male and female above 18 years. Data was collected through a self-constructed validated questionnaire and was analyzed through SPSS 25.
Results:Out of total 403, 219 (54.3%) did not reported any AEFI, 184 (45.4%) complaint of mild and only one (0.2%) reported severe AEFI. The most common AEFI was pain at the injection site 99 (24.6%) followed by mild fever 20 (5.0%), body aches 17(4.2%) and headache 13 (3.2%). 165 (40.9 %) observed the AEFI within 48 hours while 238 (59%) observed it after 48 hours of immunization. Only 8 (2%) pregnant women and 11(2.7%) lactating mothers vaccinated themselves.
Conclusion:Majority of the study population in KP did not suff er from any AEFIs after COVID 19 vaccination. Pregnant and lactating mothers were hesitant to vaccinate.

Downloads

Published

2022-06-30

How to Cite

Ayesha Zafar, Saima Abid, Naveeda Sarwar, Nauman Khan, Nauman Khan, Abdul Basit, Rida Ubaid, Zarafshan Johar, Ulfat Kamal, Hira Afridi, Shehryar Khan, Lutfullah, Abdul Majid, Mian Haider Khan, M. Talha Khan, & Adil Zareef. (2022). ADVERSE EFFECTS FOLLOWING COVID-19 IMMUNIZATION IN KHYBER PAKHTUNKHWA: PAKISTAN. JOURNAL OF KHYBER COLLEGE OF DENTISTRY, 12(2), 18–22. https://doi.org/10.33279/jkcd.v12i2.53

Issue

Vol. 12 No. 2 (2022): Journal of Khyber College of Dentistry

Section

Original Article

License

Copyright (c) 2022 Ayesha Zafar, Saima Abid , Naveeda Sarwar, Nauman Khan, Nauman Khan, Abdul Basit, Rida Ubaid, Zarafshan Johar, Ulfat Kamal, Hira Afridi, Shehryar Khan, Lutfullah, Abdul Majid, Mian Haider Khan, M. Talha Khan, Adil Zareef

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format
  2. Adapt — remix, transform, and build upon the material
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. NonCommercial — You may not use the material for commercial purposes .
  3. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.